Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Bakris GL; GEMINI Investigators.

J Cardiometab Syndr. 2008 Fall;3(4):211-7. doi: 10.1111/j.1559-4572.2008.00017.x.

2.

Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol.

Kveiborg B, Christiansen B, Major-Petersen A, Torp-Pedersen C.

Am J Cardiovasc Drugs. 2006;6(4):209-17. Review.

PMID:
16913822
3.
4.

Carvedilol in hypertension treatment.

Stafylas PC, Sarafidis PA.

Vasc Health Risk Manag. 2008;4(1):23-30. Review.

5.

Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.

Bauman JL, Talbert RL.

J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):117-28. Review.

PMID:
15309248
6.

Use of carvedilol in hypertension: an update.

Leonetti G, Egan CG.

Vasc Health Risk Manag. 2012;8:307-22. doi: 10.2147/VHRM.S31578. Epub 2012 May 18. Review.

7.

β-blockers: a review of their pharmacological and physiological diversity in hypertension.

Ripley TL, Saseen JJ.

Ann Pharmacother. 2014 Jun;48(6):723-33. doi: 10.1177/1060028013519591. Epub 2014 Mar 31. Review.

PMID:
24687542
8.

Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension.

Bakris GL, Weber MA.

Rev Cardiovasc Med. 2008 Spring;9(2):96-105. Review.

PMID:
18660730
9.

Advantages of a third-generation beta-blocker in patients with diabetes mellitus.

Bell DS.

Am J Cardiol. 2004 May 6;93(9A):49B-52B. Review.

PMID:
15144938
10.

[Prevention and treatment of congestive heart failure in diabetic patients].

Anguita Sánchez M.

Rev Esp Cardiol. 2002 Oct;55(10):1083-7. Review. Spanish.

11.

Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol.

Lymperopoulos A, McCrink KA, Brill A.

Curr Drug Metab. 2015;17(1):30-6. Review.

PMID:
26537419
12.
13.
14.

Carvedilol for hypertension.

[No authors listed]

Drug Ther Bull. 1995 May;33(5):39-40. Review. No abstract available.

PMID:
7587995
15.

[Arterial hypertension in diabetes mellitus: classical concepts and modern tendencies].

Mamedov MN.

Kardiologiia. 2013;53(1):87-90. Review. Russian.

PMID:
23548356
16.

Beers list: what's NOT on "tap" for the older adult.

Donatelli NS, Somes J.

J Emerg Nurs. 2013 Sep;39(5):491-4. doi: 10.1016/j.jen.2013.07.008. Review. No abstract available.

PMID:
23998227
17.

Novel treatment approaches in hypertensive type 2 diabetic patients.

Castro Torres Y, Katholi RE.

World J Diabetes. 2014 Aug 15;5(4):536-45. doi: 10.4239/wjd.v5.i4.536. Review.

Supplemental Content

Support Center